Company intelligence / Profile preview
Lysoway Therapeutics
Not specified (likely Boston/Cambridge area based on industry norms), Massachusetts, United Stateslysoway.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Lysoway Therapeutics has developed proprietary technologies to screen and develop potent modulators of lysosomal ion channels. The company focuses on advancing novel therapies for neurodegenerative diseases and metabolic disorders. As of May 2025, it remains at the discovery/preclinical stage with no disclosed clinical results or late-stage programs.
- Therapeutic areas
- Metabolic DisordersNeurology
- Modalities
- Small moleculesPotentially others
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Lysoway Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lysoway Therapeutics.